Health News

  • Today August 7
Jul 08, 2020 08:53 KST
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
Boehringer Ingelheim and Numab Therapeutics (Numab) today announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects aiming at no
Jul 07, 2020 13:15 KST
Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®
Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients
Jul 03, 2020 14:00 KST
EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-co
Jul 03, 2020 13:30 KST
Urethral Stricture Treatment by Hybrid Cell Therapy, Granted Japanese Patent
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients
Jul 02, 2020 15:20 KST
Smiths Detection enters into agreement to acquire PathSensors to expand its biological-detection capability
Smiths Detection, a global leader in detection and screening technologies, today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environm
Jul 01, 2020 17:55 KST
Laboratory Studies Confirm the Effectiveness of BETADINE® Gargle and Mouthwash Against COVID-19 Virus
Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia, has confirmed the effectiveness of BETADINE® Gargle and M
Jun 30, 2020 13:55 KST
PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of the expansion of its new Biotech Center of Excellence
Jun 30, 2020 09:00 KST
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy for Acute Liver Failure
GoLiver Therapeutics, a start-up focused on the development of Innovative Therapy Medicines, in particular cell therapy products for life-threatening liver diseases without the need for transplant usi
Jun 29, 2020 18:00 KST
Teijin Receives Marketing Approval for Merz’s Xeomin® Botulinum Toxin Type A in Japan
Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly an
Jun 25, 2020 16:45 KST
London Scientific Researchers Publish Study Proving the Quality of Bovine Colostrum Sourcing Can Significantly Impact Health Benefits
A newly published study from scientific researchers based at University of Plymouth, UK, Queen Mary University of London and colostrum-based nutrition company, PanTheryx of Boulder, Colorado reveals t
Jun 23, 2020 17:00 KST
Illumina’s Noninvasive Prenatal Screening Kit Receives Regulatory Approval in S. Korea
On June 23, 2020, Illumina, a global leader in DNA sequencing and array-based technologies, announced it has received regulatory approval from South Korea’s Ministry of Food and Drug Safety (MFDS) of
Jun 23, 2020 11:25 KST
Japanese Dietary Supplement: Nichi Glucan, an Immune Booster in Covid-19
A unique Beta 1,3-1,6 Glucan based Japanese health supplement, produced by black yeast, Aureobasidium Pullulans, could strategically help tackle Covid-19 in people with comorbid conditions like diabet
Jun 19, 2020 16:30 KST
Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of TERN-101 for the Treatment of NASH
Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, today announced that it has screened the f
Jun 19, 2020 14:10 KST
Cell Therapy Tools for Cartilage Repair From Osteoarthritic Knee Joint of Elderly
A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee joints of elderly has been reported by orthopedicians and cell culture experts
Jun 18, 2020 17:55 KST
Patient Safety Movement Foundation Previews Its World Patient Safety Day Campaign, Centered on Health Worker Safety
Today, the Patient Safety Movement Foundation (PSMF) unveiled its early plans aligned with the World Health Organization’s (WHO) World Patient Safety Day on September 17, 2020. This year, WHO is focus
Jun 18, 2020 16:40 KST
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
Neurocrine Biosciences, Inc. (Nasdaq:NBIX) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced a strategic collaboration to develop and commercialize compounds in
Jun 18, 2020 14:00 KST
CDKL5 Deficiency Disorder Voice of the Patient Report Submitted to FDA
Understanding the patient voice is fundamental for therapy development. Companies need to ensure that what matters most to patients is being assessed, and regulators and payers asks for demonstration
Jun 18, 2020 11:40 KST
SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has partnered with Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics, in a non-exclusi
Jun 17, 2020 17:50 KST
Taiwan Prepared for the Post-Covid-19 Era With Emerging Technologies
The Covid-19 pandemic spurs transformation of digital healthcare everywhere. To echo that trend, the Healthcare+ Expo Taiwan will bring together 300 technology giants and healthcare providers to exhib
Jun 17, 2020 15:20 KST
Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus
Molecular diagnostics company Lucence and the Agency for Science, Technology and Research (A*STAR) today announced study results indicating that the reagent used in Lucence’s SAFER Sample saliva colle
Jun 16, 2020 10:30 KST
Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study for Peripheral T-Cell Lymphoma
Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, President & CEO: Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today announced the positive results fr
Jun 15, 2020 17:37 KST
Takeda Provides Updates on its Hemophilia Studies at WFH 2020, Reinforcing its Commitment to Putting Patients First and Supporting Personalized Care for People with Bleeding Disorders
Takeda Pharmaceutical Company Limited, (“Takeda”) (TSE: 4502/NYSE:TAK) today announced a scientific update from the AHEAD real-world study investigating the long-term outcomes associated with ADVATE [
Jun 15, 2020 16:43 KST
Marc Princen appointed new Global CEO for Mundipharma
FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated companies as the Global Chief Executive Officer, e
Jun 15, 2020 11:15 KST
Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO™ (ixazomib) in Multiple Myeloma as a First-Line Maintenance Therapy
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced it will orally present the results of two studies at the 25th Congress of the European Hematology Association (EHA)
Jun 12, 2020 13:55 KST
Takeda to Divest OTC and Select Non-core Assets in Asia Pacific to Celltrion for up to $278 Million USD
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescript
25 per page50 per page75 per page100 per page